Difficulty: Medium
Average Score: 67%
Testbank
A client with HIV will be started on a medication regimen of three medications. What class of drugs will the nurse instruct the client about?
Correct answer
C
Rationale
Reverse transcriptase inhibitors are a class of antiretroviral drugs used to manage HIV infection by inhibiting the reverse transcriptase enzyme, crucial for viral replication.
Reverse transcriptase inhibitors are essential in HIV treatment regimens as they prevent the virus from converting its RNA into DNA, thereby halting its ability to replicate and spread in the body. This class of medications is foundational in antiretroviral therapy, often combined with other drug classes for effective management of HIV.
A: Anticholinergics are primarily used to treat conditions such as asthma and gastrointestinal disorders, not for managing HIV, making them unsuitable for this client's medication regimen.
B: Disinhibitors are not a recognized class of medications used in HIV treatment; they do not play a role in the pharmacological management of viral infections like HIV.
D: Hydroxyurea is used mainly for certain blood disorders and cancers, not for HIV treatment, and does not target the viral replication process effectively as reverse transcriptase inhibitors do.
Reverse transcriptase inhibitors are essential in HIV treatment regimens as they prevent the virus from converting its RNA into DNA, thereby halting its ability to replicate and spread in the body. This class of medications is foundational in antiretroviral therapy, often combined with other drug classes for effective management of HIV.
A: Anticholinergics are primarily used to treat conditions such as asthma and gastrointestinal disorders, not for managing HIV, making them unsuitable for this client's medication regimen.
B: Disinhibitors are not a recognized class of medications used in HIV treatment; they do not play a role in the pharmacological management of viral infections like HIV.
D: Hydroxyurea is used mainly for certain blood disorders and cancers, not for HIV treatment, and does not target the viral replication process effectively as reverse transcriptase inhibitors do.